PHSC PLC
LSE:PHSC
Relative Value
The Relative Value of one
PHSC
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 8 GBX,
PHSC PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PHSC Competitors Multiples
PHSC PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
PHSC PLC
LSE:PHSC
|
822.5k GBP | 0.3 | -3.7 | -4.2 | -4.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.2B USD | 0.2 | 55.7 | 14.1 | 14.1 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66B EUR | 0.3 | 12.9 | 7.6 | 9.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.3B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.4B EUR | 1.2 | 20.8 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD | 1.6 | 25.3 | 12.2 | 17.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.3B USD | 2 | 22.4 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.3B USD | 11.5 | -27.1 | -29.2 | -26.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 0.8 | 14.2 | 7.4 | 10 |